ExodusPoint Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $404K | Sell |
165,037
-35,647
| -18% | -$87.3K | ﹤0.01% | 1131 |
|
|
2025
Q1 | $1.34M | Buy |
200,684
+10,805
| +6% | +$72.1K | 0.01% | 786 |
|
|
2024
Q4 | $2.39M | Buy |
189,879
+124,261
| +189% | +$1.56M | 0.02% | 603 |
|
|
2024
Q3 | $1.21M | Buy |
+65,618
| New | +$1.21M | 0.01% | 860 |
|
|
2023
Q3 | – | Sell |
-34,798
| Closed | -$691K | – | 1975 |
|
|
2023
Q2 | $691K | Sell |
34,798
-271,264
| -89% | -$5.39M | 0.01% | 1150 |
|
|
2023
Q1 | $5.24M | Buy |
+306,062
| New | +$5.24M | 0.04% | 415 |
|
|
2022
Q4 | – | Sell |
-37,402
| Closed | -$597K | – | 1981 |
|
|
2022
Q3 | $597K | Buy |
37,402
+19,727
| +112% | +$315K | 0.01% | 1270 |
|
|
2022
Q2 | $243K | Sell |
17,675
-2,819
| -14% | -$38.8K | ﹤0.01% | 1555 |
|
|
2022
Q1 | $325K | Buy |
+20,494
| New | +$325K | ﹤0.01% | 1670 |
|
|
2021
Q1 | – | Sell |
-36,085
| Closed | -$1.98M | – | 2448 |
|
|
2020
Q4 | $1.98M | Buy |
36,085
+6,516
| +22% | +$357K | 0.02% | 508 |
|
|
2020
Q3 | $676K | Buy |
+29,569
| New | +$676K | 0.01% | 806 |
|
|
2020
Q1 | – | Sell |
-31,054
| Closed | -$707K | – | 1486 |
|
|
2019
Q4 | $707K | Buy |
31,054
+18,454
| +146% | +$420K | 0.01% | 636 |
|
|
2019
Q3 | $147K | Buy |
+12,600
| New | +$147K | 0.01% | 1159 |
|